Background: We previously confirmed in humans the existence of a pathway of glutamine into citrulline and arginine, which is preferentially stimulated by luminally provided glutamine. However, because glutamine is unstable, we tested this pathway with a stable dipeptide of glutamine. Objectives: The objectives were to explore whether alanyl-glutamine contributes to the synthesis of arginine in humans and whether this depends on the route of administration. Design: The study was conducted under postabsorptive conditions during surgery. Sixteen patients received alanyl-[2-15N]glutamine enterally or intravenously together with intravenously administered stable-isotope tracers of citrulline and arginine. Blood was collected from an artery, the portal vein, a hepatic vein, and the right renal vein. Arterial and venous enrichments and (tracer) net balances of alanyl-glutamine and glutamine, citrulline, and arginine across the portal-drained viscera, liver, and kidneys were determined. Parametric tests were used to test results (mean ± SEM). P < 0.05 was considered significant. Results: Twice as much exogenous glutamine was used for the synthesis of citrulline when alanyl-glutamine was provided enterally (5.9 ± 0.6%) than when provided intravenously (2.8 ± 0.3%) (P < 0.01). Consequently, twice as much exogenous glutamine was used for the synthesis of arginine when alanyl-glutamine was provided enterally (5 ± 0.7%) than when provided intravenously (2.4 ± 0.2%) (P < 0.01). However, results at the organ level did not explain the differences due to route of administration. Conclusions: Alanyl-glutamine contributes to the de novo synthesis of arginine, especially when provided enterally. A stable-isotope study using a therapeutic dose of alanyl-glutamine is needed to investigate the clinical implications of this finding. © 2009 American Society for Nutrition.
CITATION STYLE
Ligthart-Melis, G. C., Van De Poll, M. C. G., Vermeulen, M. A. R., Boelens, P. G., Van Den Tol, M. P., Van Schaik, C., … Van Leeuwen, P. A. M. (2009). Enteral administration of alanyl-[2-15N]glutamine contributes more to the de novo synthesis of arginine than does intravenous infusion of the dipeptide in humans. American Journal of Clinical Nutrition, 90(1), 95–105. https://doi.org/10.3945/ajcn.2008.26399
Mendeley helps you to discover research relevant for your work.